BMO Capital Markets’ price target suggests a potential upside of 24.89% from the stock’s current price. A number of other brokerages have also issued reports on PTGX.

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

GE Vernova (NYSE:GEV – Free Report) had its price objective lowered by BMO Capital Markets from $471.00 to $420.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has ...

A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...

Investing.com -- BMO Capital Markets upgraded Century Aluminum Company (NASDAQ:CENX) to "Outperform" from "Market Perform" given its favourable valuation following a recent sell-off and the ...

BMO Capital analyst Keith Bachman initiated coverage of SailPoint (SAIL) with an Outperform rating and $26 price target The firm believes ...

BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...